Table 3.

Clinical and laboratory data of renal patients with and without CV events during follow-up

CV Events(n = 10)No CV Events(n = 167)
Gender (male/female [%])9/1 (90/10)109/58 (65/35)
Age (yr)53.5 ± 7.1 45.9 ± 12.3
Body mass index (kg/m2)26.1 ± 1.6 25.1 ± 3.8 
Current smoker (n)1 (10%)33 (20%)
Past smoker (n)1 (10%)43 (19%)
Previous CV event2 (20%)20 (26%)
Serum creatinine (mg/dl)1.96 (1.39 to 2.88)1.70 (1.22 to 2.76)
GFR (ml/min per 1.73 m2)39 (32 to 60)57 (37 to 90)
Proteinuria (g/24 h per 1.73 m2)0.30 (0.09 to 2.19)0.72 (0.21 to 1.55)
High sensitivity C-reactive protein (mg/L)1.10 (0.90 to 1.51)1.70 (0.70 to 4.00)
Intact parathyroid hormone (pmol/L)7.1 (5.9 to 15.6)6.5 (3.9 to 15.3)
Systolic BP (mmHg)148 ± 24136 ± 20
Diastolic BP (mmHg)89 ± 1386 ± 13
Pulse pressure (mmHg)59 ± 2250 ± 15a
Use of antihypertensive drugs (n)10 (100%)133 (80%)
Insulin (mU/L)14.1 ± 6.513.5 ± 9.9
Glucose (mg/dl)110 ± 2597 ± 15b
HOMA-IR4.02 ± 2.863.43 ± 3.56
Adiponectin (μg/ml)3.0 ± 1.36.5 ± 4.5a
Total cholesterol (mg/dl)215 ± 33216 ± 44
LDL cholesterol (mg/dl)137 ± 29138 ± 39
Triglycerides (mg/dl)157 (106 to 286)144 (104 to 221)
  • a P < 0.05, patients with and without CV events.

  • b P < 0.01, patients with and without CV events.